New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year, study finds

byUniversity of MichiganCredit: Ivan Samkov from PexelsAs prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for m

Oncology September 28,2024 0

New law regulating out-of-pocket drug spending saves cancer patients more than $7,000 a year, study finds

byUniversity of MichiganCredit: Ivan Samkov from PexelsAs prescription oral chemotherapies have become a common form of cancer treatment, some patients were paying more than $10,000 a year for m

Oncology September 28,2024 0

Study identifies five key factors that predict response of cancer patients to immunotherapy

byInstitute for Research in Biomedicine (IRB Barcelona)Credit: Unsplash/CC0 Public DomainA team of researchers at IRB Barcelona has identified five independent factors that predict cancer patien

Oncology September 28,2024 0

Study identifies five key factors that predict response of cancer patients to immunotherapy

byInstitute for Research in Biomedicine (IRB Barcelona)Credit: Unsplash/CC0 Public DomainA team of researchers at IRB Barcelona has identified five independent factors that predict cancer patien

Oncology September 28,2024 0

Why a promising breast cancer drug doesn't work—and how to improve it

by Katherine Fenz,Rockefeller UniversityER-mediated transcriptional resistance to BD inhibition. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s41594-024-01384

Oncology September 28,2024 0

Why a promising breast cancer drug doesn't work—and how to improve it

by Katherine Fenz,Rockefeller UniversityER-mediated transcriptional resistance to BD inhibition. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s41594-024-01384

Oncology September 28,2024 0

New mammogram rule gives women more details to guard against breast cancer

by Helena Oliviero, The Atlanta Journal-ConstitutionCredit: Unsplash/CC0 Public DomainA new federal rule takes effect Tuesday that could potentially help more women spot breast cancer earlier. The FDA

Oncology September 28,2024 0

New mammogram rule gives women more details to guard against breast cancer

by Helena Oliviero, The Atlanta Journal-ConstitutionCredit: Unsplash/CC0 Public DomainA new federal rule takes effect Tuesday that could potentially help more women spot breast cancer earlier. The FDA

Oncology September 28,2024 0

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

by ECOG-ACRIN Cancer Research GroupCredit: CC0 Public DomainResults from a clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) show a striking improvement for patients who received che

Oncology September 28,2024 0

Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal

by ECOG-ACRIN Cancer Research GroupCredit: CC0 Public DomainResults from a clinical trial by the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) show a striking improvement for patients who received che

Oncology September 28,2024 0

Common diabetes drug slows growth of normal cells carrying cancer mutation, finds study

byWellcome Trust Sanger InstitutePIK3CA mutant clones in human esophageal epithelium. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01891-8A common diabetes medication, metfo

Oncology September 28,2024 0

Common diabetes drug slows growth of normal cells carrying cancer mutation, finds study

byWellcome Trust Sanger InstitutePIK3CA mutant clones in human esophageal epithelium. Credit:Nature Genetics(2024). DOI: 10.1038/s41588-024-01891-8A common diabetes medication, metfo

Oncology September 28,2024 0

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta

Oncology September 27,2024 0

Telisotuzumab vedotin shows durable response in some Asian patients with nonsquamous NSCLC

by International Association for the Study of Lung CancerCredit: Pixabay/CC0 Public DomainThe c-Met-directed antibody-drug conjugate telisotuzumab vedotin demonstrated durable responses and an accepta

Oncology September 27,2024 0

Sex matters in how, when, and where melanomas develop

byElsevierFitted temporal trend of invasive cutaneous melanoma incidence (1982- 2018) for males vs. females from three populations (Queensland, US Whites, Scotland), by body site. Credit:J

Dermatology September 27,2024 0

Sex matters in how, when, and where melanomas develop

byElsevierFitted temporal trend of invasive cutaneous melanoma incidence (1982- 2018) for males vs. females from three populations (Queensland, US Whites, Scotland), by body site. Credit:J

Dermatology September 27,2024 0

New multimodal signature could predict immunotherapy success

byUniversity of InnsbruckCredit:iScience(2024). DOI: 10.1016/j.isci.2024.110529An international team of researchers led by Francesca Finotello from the Digital Science Center (DiSC)

Oncology September 27,2024 0

New multimodal signature could predict immunotherapy success

byUniversity of InnsbruckCredit:iScience(2024). DOI: 10.1016/j.isci.2024.110529An international team of researchers led by Francesca Finotello from the Digital Science Center (DiSC)

Oncology September 27,2024 0

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Oncology September 27,2024 0

Double trouble for triple-negative breast cancer: Two-pronged strategy restores immunotherapy sensitivity

by Kimberly McGhee,Medical University of South CarolinaTumor-fighting immune cells in the tumor before (left) and after (right) combination therapy. After combination therapy, many more tumor-fi

Oncology September 27,2024 0